Search by Drug Name or NDC
NDC 00832-1218-00 Jantoven 7.5 mg/1 Details
Jantoven 7.5 mg/1
Jantoven is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Upsher-Smith Laboratories, LLC. The primary component is WARFARIN SODIUM.
MedlinePlus Drug Summary
Warfarin is used to prevent blood clots from forming or growing larger in your blood and blood vessels. It is prescribed for people with certain types of irregular heartbeat, people with prosthetic (replacement or mechanical) heart valves, and people who have suffered a heart attack. Warfarin is also used to treat or prevent venous thrombosis (swelling and blood clot in a vein) and pulmonary embolism (a blood clot in the lung). Warfarin is in a class of medications called anticoagulants ('blood thinners'). It works by decreasing the clotting ability of the blood.
Related Packages: 00832-1218-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Warfarin
Product Information
| NDC | 00832-1218 |
|---|---|
| Product ID | 0832-1218_6bf07384-92a7-4543-9797-2edc079a9cbe |
| Associated GPIs | 83200030200320 |
| GCN Sequence Number | 006563 |
| GCN Sequence Number Description | warfarin sodium TABLET 7.5 MG ORAL |
| HIC3 | M9L |
| HIC3 Description | ANTICOAGULANTS,COUMARIN TYPE |
| GCN | 25795 |
| HICL Sequence Number | 002812 |
| HICL Sequence Number Description | WARFARIN SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Jantoven |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Warfarin Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 7.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | WARFARIN SODIUM |
| Labeler Name | Upsher-Smith Laboratories, LLC |
| Pharmaceutical Class | Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040416 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00832-1218-00 (00832121800)
| NDC Package Code | 0832-1218-00 |
|---|---|
| Billing NDC | 00832121800 |
| Package | 100 TABLET in 1 BOTTLE (0832-1218-00) |
| Marketing Start Date | 2010-02-23 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.1101 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | JANTOVEN 7.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis